Curanex Pharmaceuticals Reports Unregistered Equity Sales
Ticker: CURX · Form: 8-K · Filed: Sep 29, 2025 · CIK: 2025942
| Field | Detail |
|---|---|
| Company | Curanex Pharmaceuticals Inc (CURX) |
| Form Type | 8-K |
| Filed Date | Sep 29, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $200,000, $400,000, $8,537.32, $26,182.68 |
| Sentiment | neutral |
Sentiment: neutral
Topics: unregistered-sales, equity-securities, 8-k
TL;DR
Curanex sold unregistered shares, watch for dilution.
AI Summary
Curanex Pharmaceuticals Inc. filed an 8-K on September 29, 2025, reporting unregistered sales of equity securities and other events that occurred on September 23, 2025. The filing also includes financial statements and exhibits.
Why It Matters
This filing indicates potential dilution for existing shareholders due to the sale of unregistered equity, which could impact the stock price.
Risk Assessment
Risk Level: medium — Unregistered sales of equity can lead to dilution and may signal a need for capital, potentially impacting stock value.
Key Players & Entities
- Curanex Pharmaceuticals Inc (company) — Registrant
- September 23, 2025 (date) — Date of earliest event reported
- September 29, 2025 (date) — Date of report
- Nevada (jurisdiction) — State of incorporation
- 2 Jericho Plaza, Suite 101B Jericho, NY 11753 (address) — Principal executive offices
FAQ
What type of securities were sold in the unregistered offering?
The filing states 'Unregistered Sales of Equity Securities' but does not specify the exact type of equity in the provided text.
Were there any specific dollar amounts associated with the unregistered equity sales?
The provided text does not mention specific dollar amounts for the unregistered equity sales.
What is the IRS Employer Identification Number for Curanex Pharmaceuticals Inc?
The IRS Employer Identification Number for Curanex Pharmaceuticals Inc. is 83-0741390.
What is the Commission File Number for Curanex Pharmaceuticals Inc?
The Commission File Number for Curanex Pharmaceuticals Inc. is 001-42815.
What is the SIC code for Curanex Pharmaceuticals Inc?
The Standard Industrial Classification (SIC) code for Curanex Pharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 862 words · 3 min read · ~3 pages · Grade level 11.6 · Accepted 2025-09-29 15:55:37
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share CURX The Nasdaq Capital M
- $200,000 — s of the Agreement, in consideration of $200,000 subscribed for by Mr. Song, the Shares
- $400,000 — ns in the aggregate principal amount of $400,000, including $200,000 loan received on Fe
- $8,537.32 — cludes $400,000 in principal amount and $8,537.32 in total accrued interest, including (i
- $26,182.68 — standing debt, as well as approximately $26,182.68 of interest charges that would have bee
Filing Documents
- form8-k.htm (8-K) — 44KB
- 0001493152-25-015986.txt ( ) — 209KB
- curx-20250923.xsd (EX-101.SCH) — 3KB
- curx-20250923_lab.xml (EX-101.LAB) — 33KB
- curx-20250923_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Curanex Pharmaceuticals Inc Date: September 29, 2025 By: /s/ Jun Liu Name: Jun Liu Title: Chief Executive Officer